Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Inorg Biochem. 2016 Jul 27;165:170–180. doi: 10.1016/j.jinorgbio.2016.07.016

Figure 4. Quantification of P3A1-MWCNT[1] induced cytotoxicity in breast cancer cells.

Figure 4

(A) MDA-MB-231 were treated for 24, 48, and 72 h, or (B) MDA-MB-468, BT20, MDA-MB-436 or SUM159 were treated for 48 h with P3A1-MWCNT[1], DSPE-mPEG coated MWCNT (0–26 µg/mL), P3A1 (0–20 µM), or equivalent doses of P3A1-MWCNT[1]. Data are shown as relative viability assessed by CellTiter Glo assay compared to untreated control ± SD.